Parkinson's Disease Trial, Recruiting NCT07625540 Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT07625540
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 50 and 85 years, of any sex.
  • People who have been diagnosed with "clinically established" or "clinically probable" Parkinson's disease based on recognised 2015 diagnostic guidelines.
  • People whose Parkinson's disease has progressed to at least stage 2 on a standard rating scale, and who are able to complete assessment questionnaires and MRI scans as judged by the study doctor.
  • People who have been on a stable Parkinson's medication routine for at least 4 weeks before joining, and who are willing to keep that routine unchanged during the main part of the study unless a medical reason requires a change.
  • People who are able to provide written consent to participate in the study.

Who may not be able to join:

  • People whose parkinsonism is caused by something other than primary Parkinson's disease, or who have an atypical or secondary form of the condition.
  • People who have previously had brain surgery or an implanted brain stimulation device, such as deep brain stimulation (DBS).
  • People who have metal implants or implanted electrical devices that are not compatible with transcranial electrical stimulation (a type of non-invasive brain stimulation used in this trial), or who are considered unsuitable for this treatment by the study doctor for any other reason.
  • People who have received non-invasive brain stimulation treatments — such as transcranial magnetic stimulation or transcranial electrical stimulation — within the past six months.
  • People who have a medical reason preventing them from having an MRI scan, or who are unable to tolerate the MRI procedure.
  • People with significant memory or thinking difficulties, or severe mental health symptoms, that would prevent them from completing the study assessments or following the study requirements.
  • People who have started a new medication or had a dose change in the past 4 weeks for something that significantly affects sleep or level of consciousness.
  • People with a history of epilepsy.
  • People who are pregnant or breastfeeding.
  • People considered unsuitable for any other reason, as determined by the study doctor.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 86-13817659260

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Registry
ClinicalTrials.gov
Start date
20 May 2026
Est. completion
1 April 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Changes of motor function in PD

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov